These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27562224)

  • 1. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-based nanoparticles as platform technologies for modern vaccines.
    Lee KL; Twyman RM; Fiering S; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):554-78. PubMed ID: 26782096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
    Lim YH; Tiemann KM; Hunstad DA; Elsabahy M; Wooley KL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):842-871. PubMed ID: 27016134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoactivated drug delivery and bioimaging.
    Yang Y; Mu J; Xing B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27094696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases.
    Jo DH; Kim JH; Lee TG; Kim JH
    Nanomedicine; 2015 Oct; 11(7):1603-11. PubMed ID: 25989200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle formulations of cisplatin for cancer therapy.
    Duan X; He C; Kron SJ; Lin W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):776-91. PubMed ID: 26848041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging.
    Sangtani A; Nag OK; Field LD; Breger JC; Delehanty JB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28299903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crossing the barrier: treatment of brain tumors using nanochain particles.
    Karathanasis E; Ghaghada KB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):678-95. PubMed ID: 26749497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy.
    Zheng M; Tao W; Zou Y; Farokhzad OC; Shi B
    Trends Biotechnol; 2018 May; 36(5):562-575. PubMed ID: 29422412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.
    Colby AH; Oberlies NH; Pearce CJ; Herrera VL; Colson YL; Grinstaff MW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 28185434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.
    Kelley WJ; Safari H; Lopez-Cazares G; Eniola-Adefeso O
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):909-926. PubMed ID: 27194461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine.
    Sierri G; Patrucco M; Ferrario D; Renda A; Comi S; Ciprandi M; Fontanini V; Sica FS; Sesana S; Costa Verdugo M; Kravicz M; Salassa L; Busnelli M; Re F
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(5):e1991. PubMed ID: 39251878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimer-based nanocarriers: a versatile platform for drug delivery.
    Hsu HJ; Bugno J; Lee SR; Hong S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27126551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.
    Bisht R; Mandal A; Jaiswal JK; Rupenthal ID
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28425224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotherapeutic systems for local treatment of brain tumors.
    Chakroun RW; Zhang P; Lin R; Schiapparelli P; Quinones-Hinojosa A; Cui H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jan; 10(1):. PubMed ID: 28544801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Nanomedicine to the CNS Diseases.
    Carradori D; Gaudin A; Brambilla D; Andrieux K
    Int Rev Neurobiol; 2016; 130():73-113. PubMed ID: 27678175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming in vivo barriers to targeted nanodelivery.
    Chrastina A; Massey KA; Schnitzer JE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):421-37. PubMed ID: 21538941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT; Kostarelos K
    Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.